Nina Peterson, CANS
Nina Peterson is a Certified Aesthetic Nurse Specialist (CANS) specializing in facial contouring and non-surgical mini facelifts with PDO threads. With over nine years of experience gained in dermatology and plastic surgery practices, Nina also works as a medical blogger and consultant for aesthetic practices and licensed individuals, bringing her background in plastic surgery and dermatology to provide valuable insights.
author’s articles

Is Liztox FDA Approved?
In an increasingly crowded landscape of aesthetic injectables, regulatory approval remains a vital benchmark for both safety and credibility. As...
Read More
Liztox Reviews – Patient and Practitioner Perspectives
Clinical literature reviews are vital for evidence-based medicine, providing synthesized findings from multiple studies that help shape clinical guidelines, policy...
Read More
Liztox vs Nabota – How Do The Korean Botulinum Toxins Compare?
With over 9 million botulinum toxin injections administered globally in a single year, according to the International Society of Aesthetic...
Read More
Liztox Manufacturer – About Huons Biopharma Co., Ltd.
Did you know that 9.8 million botulinum toxin type A injections were administered in the United States in 2024? According...
Read More
How to Buy SCULPTRA® on Medica Depot
It has never been easier to order SCULPTRA® dermal fillers to stock your medical practice. Medica Depot is the absolute...
Read More
How To Buy RESTYLANE® Fillers on Medica Depot
You’re looking to order RESTYLANE® dermal fillers to stock your medical practice? Congratulations – you’ve found the absolute best place...
Read More
Saphnelo FDA Approval Status
In 2021, the FDA granted approval to two important targeted therapies for lupus: voclosporin for lupus nephritis and anifrolumab for...
Read More
The Regenerative Aesthetics Guide: Exosomes, Stem Cells, and What’s Next in Skincare
What Is Regenerative Aesthetics? In recent years, regenerative aesthetics has emerged as one of the most talked-about frontiers in skin...
Read More
Saphnelo Generic Name – Anifrolumab
In a post hoc pooled analysis of the TULIP-1 and TULIP-2 Phase III trials, patients treated with anifrolumab—the generic name...
Read More
Saphnelo Prescribing Information For Practitioners
A 2022 publication from the US Food and Drug Administration (FDA) highlighted the critical role of prescribing information as the...
Read More